Nephros (NEPH) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Nephros (NEPH) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.25% |
| Dec 31, 2025 | 15.73% |
| Sep 30, 2025 | 18.27% |
| Jun 30, 2025 | 16.41% |
| Mar 31, 2025 | 20.12% |
| Dec 31, 2024 | 30.44% |
| Sep 30, 2024 | 17.37% |
| Jun 30, 2024 | 22.03% |
| Mar 31, 2024 | 34.02% |
| Dec 31, 2023 | 2.81% |
| Sep 30, 2023 | 19.61% |
| Jun 30, 2023 | 8.63% |
| Mar 31, 2023 | 24.01% |
| Dec 31, 2022 | -13.56% |
| Sep 30, 2022 | -39.80% |
| Jun 30, 2022 | -9.53% |
| Mar 31, 2022 | -24.82% |
| Dec 31, 2021 | -10.45% |
| Sep 30, 2021 | -11.76% |
| Jun 30, 2021 | -7.27% |